Patents by Inventor Yanjiang WANG

Yanjiang WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treatment of cerebral amyloid angiopathy with P75ECD peptide and/or P75ECD-FC fusion protein
    Patent number: 11046746
    Abstract: A method of treating and/or preventing neurological conditions, comprising administering to a subject in need thereof a therapeutically effective amount of a p75 extracellular domain (p75ECD) or a functional fragment, variant, analogue or derivative thereof. Also provided is a method of diagnosing and/or prognosing Alzheimer's disease (AD) in a test subject comprising comparing the concentration of p75ECD and/or p75FL and/or the ratio of p75ECD:p75FL in a biological sample of the test subject to non-demented control subject(s).
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: June 29, 2021
    Inventors: Xinfu Zhou, Yanjiang Wang
  • METHOD OF DIAGNOSIS OR TREATMENT OF NEUROLOGICAL DISORDERS WITH P75ECD AND/OR P75
    Publication number: 20180170996
    Abstract: A method of treating and/or preventing neurological conditions, comprising administering to a subject in need thereof a therapeutically effective amount of a p75 extracellular domain (p75ECD) or a functional fragment, variant, analogue or derivative thereof. Also provided is a method of diagnosing and/or prognosing Alzheimer's disease (AD) in a test subject comprising comparing the concentration of p75ECD and/or p75FL and/or the ratio of p75ECD:p75FL in a biological sample of the test subject to non-demented control subject(s).
    Type: Application
    Filed: March 25, 2016
    Publication date: June 21, 2018
    Inventors: Xinfu ZHOU, Yanjiang WANG
  • METHODS OF PREVENTING AND TREATING CEREBRAL AMYLOID ANGIOPATHY (CAA) WITH AN EDARAVONE MEDICAMENT
    Publication number: 20170312253
    Abstract: The present invention belongs to pharmaceutical field, specifically, relates to use of Edaravone in the preparation of a medicament for preventing and treating cerebral amyloid angiopathy (CAA). By administering Edaravone, the present invention could scavenge the deposited amyloid (A?) in the brain and prevent the intracerebral A? deposition.
    Type: Application
    Filed: November 5, 2015
    Publication date: November 2, 2017
    Inventors: Yanjiang WANG, Shusheng JIAO, Xiuqing YAO, Xinfu ZHOU